Biography
Caleb Holland is an associate in Weil’s Regulatory Transactions Group, and is based in the Washington, D.C. office.
Caleb has been part of the teams advising:
- Astorg Partners in its approximately $282 million take-private acquisition of Hamilton Thorne and simultaneous acquisition of the Assisted Reproductive Technologies (ART) product portfolio of Cook Medical
- Bell Canada in its C$5.0 billion acquisition of Ziply Fiber
- Centerbridge Partners, L.P. and its portfolio company KIK Consumer Products Inc. in a 144A / Reg S offering of $550 million senior secured notes and $450 million senior notes
- Citation Capital in its acquisition of a majority stake in Aptive Environmental
- Corporate subsidiary of publicly-traded asset manager in its acquisition of $110 million of investment tax credits generated by two portfolios of distributed generation solar assets
- Dun & Bradstreet in its $7.7 billion sale to Clearlake Capital Group
- Emergent BioSolutions Inc. in its $250 million senior secured term loan facility and in its $100 million senior secured revolving facility
- Hologic Capital Holdings, Inc in its $350 million acquisition of Gynesonics, Inc.
- ITE Management, L.P. in its strategic minority investment from funds managed by Blackstone Credit & Insurance
- Montagu Private Equity in its acquisition of Tyber Medical LLC and combination with Intech and Resolve
- Privately-held corporation in its acquisition of $33 million of investment tax credits generated by two utility-scale solar projects
- Siete Foods in its $1.2 billion sale to PepsiCo.
Caleb received his J.D., cum laude, from The Catholic University of America, Columbus School of Law, where he served as Note and Comment Editor of the Catholic University Law Review, and Chancellor of the Catholic University Moot Court Association. He received his G.C. from Old Dominion University.